Evolent Health (EVH) PT Lowered to $14 at Truist Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts EVH Hot Sheet
Price: $4.30 --0%
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 7
Rating Summary:
20 Buy, 4 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 11 | New: 7
Join SI Premium – FREE
Truist Securities analyst Jailendra Singh lowered the price target on Evolent Health (NYSE: EVH) to $14.00 (from $15.00) while maintaining a Buy rating.
You May Also Be Interested In
- Beta Technologies (BETA) PT Lowered to $28 at Needham
- Hagerty Inc. (HGTY) PT Raised to $19 at Citizens on Durable Growth, Expanding Margins
- New Mountain Finance (NMFC) PT Lowered to $7 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
